These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment. Garweg JG; Zandi S; Pfister I; Rieben R; Skowronska M; Tappeiner C Acta Ophthalmol; 2019 Jun; 97(4):e580-e588. PubMed ID: 30561135 [TBL] [Abstract][Full Text] [Related]
3. Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations. Zandi S; Pfister IB; Garweg JG Sci Rep; 2021 Dec; 11(1):23989. PubMed ID: 34907233 [TBL] [Abstract][Full Text] [Related]
4. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198 [TBL] [Abstract][Full Text] [Related]
5. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882 [TBL] [Abstract][Full Text] [Related]
6. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
7. The role of thrombin in proliferative vitreoretinopathy. Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355 [TBL] [Abstract][Full Text] [Related]
8. Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Palomares-Ordóñez JL; Sánchez-Ramos JA; Ramírez-Estudillo JA; Robles-Contreras A Arch Soc Esp Oftalmol (Engl Ed); 2019 Jan; 94(1):12-17. PubMed ID: 30309666 [TBL] [Abstract][Full Text] [Related]
9. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038 [TBL] [Abstract][Full Text] [Related]
10. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001 [TBL] [Abstract][Full Text] [Related]
11. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622 [TBL] [Abstract][Full Text] [Related]
12. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Dai Y; Wu Z; Sheng H; Zhang Z; Yu M; Zhang Q Mol Vis; 2015; 21():417-27. PubMed ID: 26015767 [TBL] [Abstract][Full Text] [Related]
13. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911 [TBL] [Abstract][Full Text] [Related]
15. Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy. Ni Y; Qin Y; Huang Z; Liu F; Zhang S; Zhang Z Adv Ther; 2020 May; 37(5):2550-2559. PubMed ID: 32274748 [TBL] [Abstract][Full Text] [Related]
16. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment. Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment. Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651 [No Abstract] [Full Text] [Related]
18. Rhegmatogenous retinal detachment and conventional surgical treatment. Golubovic M Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(1):161-6. PubMed ID: 23917750 [TBL] [Abstract][Full Text] [Related]
19. [Precollagen III in the vitreous of eyes with proliferative vitreoretinopathy]. Feng X; Hui Y; Wang L Yan Ke Xue Bao; 1998 Jun; 14(2):76-9. PubMed ID: 12580036 [TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]